Potential of cancer screening with serum surface-enhanced Raman spectroscopy and a support vector machine

• Published in: Laser physics letters Vol. 11; no. 6; pp. 65603 - 65609
• Main Authors: Li, S X, Zhang, Y J, Zeng, Q Y, Li, L F, Guo, Z Y, Liu, Z M, Xiong, H L, Liu, S H
• Format: Journal Article
• Language: English
• Published: IOP Publishing 01.06.2014
• Subjects: cancer screening; serum; support vector machine; surface-enhanced Raman spectroscopy
• ISSN: 1612-2011; 1612-202X
• DOI: 10.1088/1612-2011/11/6/065603

Cancer is the most common disease to threaten human health. The ability to screen individuals with malignant tumours with only a blood sample would be greatly advantageous to early diagnosis and intervention. This study explores the possibility of discriminating between cancer patients and normal subjects with serum surface-enhanced Raman spectroscopy (SERS) and a support vector machine (SVM) through a peripheral blood sample. A total of 130 blood samples were obtained from patients with liver cancer, colonic cancer, esophageal cancer, nasopharyngeal cancer, gastric cancer, as well as 113 blood samples from normal volunteers. Several diagnostic models were built with the serum SERS spectra using SVM and principal component analysis (PCA) techniques. The results show that a diagnostic accuracy of 85.5% is acquired with a PCA algorithm, while a diagnostic accuracy of 95.8% is obtained using radial basis function (RBF), PCA-SVM methods. The results prove that a RBF kernel PCA-SVM technique is superior to PCA and conventional SVM (C-SVM) algorithms in classification serum SERS spectra. The study demonstrates that serum SERS, in combination with SVM techniques, has great potential for screening cancerous patients with any solid malignant tumour through a peripheral blood sample.